US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Biotechnology Company Reports Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Bioscience (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
EFT BioTech Holdings Inc - Company Capsule
11/13/2014 | published by: Canadean Ltd
... key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to ...  |  read more...
USD 99
Transgene SA - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Transgene SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Nocturia - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Instrumentation Engineers (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 80 largest Instrumentation Engineers (UK) companies. The Instrumentation Engineers (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
World: Case Materials - Market Report. Analysis and Forecast to 2020
11/10/2014 | published by: IndexBox Marketing Ltd.
... domestic production, exports and imports, price dynamics and trends in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of ...  |  read more...
USD 1,900
Biogen IDEC Inc (BIIB: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Biogen IDEC Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Alkermes Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... you require to better understand Alkermes and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Amgen Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Elan Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... you require to better understand Elan and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Genentech Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Genmab Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... you require to better understand Genmab and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Genzyme Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Gilead Sciences Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
USD 995
Immunomedics Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... you require to better understand Immunomedics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Amgen Inc (AMGN: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Amgen Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Gilead Sciences Inc (GILD: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Gilead Sciences Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review
10/15/2014 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Kuros Biosurgery AG - Product Pipeline Analysis, 2014 Update
10/27/2014 | published by: GlobalData
... improve mesh grafting in burns patients, KUR-213 for abdominoplasty, and KUR-023 as synthetic dural sealant. Kuros offers KUR-111 for tibial plateau fractures, KUR-112 for solitary bone cysts, and KUR-113 for tibial shaft fractures. The company ...  |  read more...
USD 750
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
10/21/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
TheraDiag SA - Product Pipeline Analysis, 2014 Update
10/17/2014 | published by: GlobalData
... system for treatment of autoimmune diseases by anti-TNFa. The company offers services in the autoimmune disease diagnostic market. It develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. The company offers ...  |  read more...
USD 750
Pharming Group N.V. (PHARM) - Financial and Strategic SWOT Analysis Review
11/3/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Genzyme Corporation
11/1/2014 | published by: SGA ExecutiveTracker
... (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all ...  |  read more...
USD 200
ImmunoGen, Inc.
11/1/2014 | published by: SGA ExecutiveTracker
... (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all ...  |  read more...
USD 30
Marina Biotech, Inc.
11/1/2014 | published by: SGA ExecutiveTracker
... (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all ...  |  read more...
USD 32
< prev 1    3  4  5  6  7  8  9  10